Prognostic value of cardiac-specific troponins in intracranial hemorrhage

Ashraf S Abdo1, Stephen A Geraci

  • 1Medical Science Department, GV (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS 39216, USA. ashraf.abdo@va.gov

Insights

Cardiac-specific troponin (Tn) elevations may associate with outcomes in patients with intracerebral hemorrhage. However, current data are insufficient to confirm consistent predictive value for prognosis.

Area of Science:

  • Cardiology
  • Neurology
  • Clinical Biomarkers

Background:

  • Cardiac-specific troponin (Tn) is a key marker for acute myocardial infarction.
  • Elevated Tn levels in noncardiac conditions like intracerebral hemorrhage (ICH) may offer prognostic insights.
  • Understanding Tn's role in ICH is crucial for patient outcome prediction.

Purpose of the Study:

  • To systematically review the literature on cardiac-specific troponin (Tn) levels and clinical outcomes in patients with intracerebral hemorrhage (ICH).
  • To assess the potential prognostic value of Tn elevations in the context of ICH.

Main Methods:

  • A systematic review of English-language medical literature was conducted using PubMed.
  • Inclusion criteria focused on articles reporting original data relevant to Tn levels and outcomes in ICH patients.

Main Results:

  • Ten studies were included in the review.
  • Cardiac abnormalities were observed in some patients with elevated Tn, but not consistently.
  • While some studies indicated worse outcomes with elevated Tn, findings were inconsistent across the literature.

Conclusions:

  • An association between cardiac-specific Tn elevations and clinical events in ICH patients is suggested by the literature.
  • Current data are insufficient to establish a consistent predictive value of Tn for prognosis in ICH.
  • Routine Tn monitoring for prognosis in ICH is not recommended at this time due to insufficient evidence.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...